To amend the Internal Revenue Code of 1986 to make a portion of research credit refundable for certain small businesses engaging in specified medical research. [HB-7556]
[Taxes ]
[Small Business ]
[Healthcare ]
[Science ]
[Public Health ]
[Pharmaceuticals ]
[National Security ]
[Funding ]
[Grants ]
[Economic Development ]
Allows certain small businesses whose gross receipts do not exceed $1 million a refundable portion of the tax credit for increasing research activities if such businesses are engaging in specified medical research. It defines specified medical research as any qualified research with respect to qualified countermeasures. A qualified countermeasure is a drug, biological product, or device that is determined to be a priority (1) to diagnose, mitigate, prevent, or treat harm from any biological agent (including organisms that cause an infectious disease)
(continued...)
HB-7556: To amend the Internal Revenue Code of 1986 to make a portion of research credit refundable for certain small businesses engaging in specified medical research.
Sponsored by: Rep. Devin Nunes
Introduced In House on 07/09/2020
You have voted HB-7556: To amend the Internal Revenue Code of 1986 to make a portion of research credit refundable for certain small businesses engaging in specified medical research..
To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities. [HB-7555]
[Healthcare ]
[Taxes ]
[Science ]
[Public Health ]
[Pharmaceuticals ]
[National Security ]
Allows a new research tax credit amount for 14% of specified medical research expenditures. It defines specified medical research expenditures as amounts paid for any qualified research with respect to any qualified countermeasure. A qualified countermeasure is a drug, biological product, or device that is determined to be a priority (1) to diagnose, mitigate, prevent, or treat harm from any biological agent (including organisms that cause an infectious disease) or toxin, chemical, radiological, or nuclear agent that may cause a public health emergency
(continued...)
HB-7555: To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.
Sponsored by: Rep. Devin Nunes
Introduced In House on 07/09/2020
You have voted HB-7555: To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities..
National Defense Authorization Act for Fiscal Year 2021 [S.4049]
[Defense ]
[Cybersecurity ]
[Artificial Intelligence ]
[Energy ]
[International ]
[National Security ]
[Military ]
[Healthcare ]
[Technology and Innovation ]
[Science ]
[Law Enforcement ]
[Budget and Spending ]
Authorizes FY2021 appropriations and sets forth policies for Department of Defense (DOD) programs and activities, including military personnel strengths. It does not provide budget authority, which is provided in subsequent appropriations legislation. The bill authorizes appropriations to DOD for Procurement, including aircraft, weapons and tracked combat vehicles, shipbuilding and conversion, and missiles; Research, Development, Test, and Evaluation; Operation and Maintenance; Working Capital Funds; Chemical Agents and Munitions Destruction; Drug
(continued...)
S.4049: National Defense Authorization Act for Fiscal Year 2021
Sponsored by: Sen. James Inhofe
Message On Senate Action Sent To The House. on 08/07/2020
National Defense Authorization Act for Fiscal Year 2021 [S.4049]
[Defense ]
[Cybersecurity ]
[Artificial Intelligence ]
[Energy ]
[International ]
[National Security ]
[Military ]
[Healthcare ]
[Technology and Innovation ]
[Science ]
[Law Enforcement ]
[Budget and Spending ]
Authorizes FY2021 appropriations and sets forth policies for Department of Defense (DOD) programs and activities, including military personnel strengths. It does not provide budget authority, which is provided in subsequent appropriations legislation. The bill authorizes appropriations to DOD for Procurement, including aircraft, weapons and tracked combat vehicles, shipbuilding and conversion, and missiles; Research, Development, Test, and Evaluation; Operation and Maintenance; Working Capital Funds; Chemical Agents and Munitions Destruction; Drug
(continued...)
S.4049: National Defense Authorization Act for Fiscal Year 2021
Sponsored by: Sen. James Inhofe
Message On Senate Action Sent To The House. on 08/07/2020
Patients Before Profits Act of 2020 [HB-7267]
[Healthcare ]
[Insurance ]
[Public Health ]
Prohibits private health insurance plans from (1) reducing reimbursement rates to health care providers, or (2) terminating a contract with a health care provider in any area where there is a federally-declared public health emergency. The bill does not limit such actions if they are based on fraud, abuse, or concern about the quality of the provider or if the provider is on the exclusion list from federal health programs that is maintained by the Department of Health and Human Services.
HB-7267: Patients Before Profits Act of 2020
Sponsored by: Rep. Jerrold Nadler
Introduced In House on 06/18/2020
Right to PROTEST Act of 2020 [HB-7196]
[Race and Civil Rights ]
[Crime ]
[Human Rights ]
[Public Safety ]
Modifies the criminal civil rights statute that prohibits the deprivation of rights under color of law. Currently, the second prong of the prohibition bars the application of different punishments, pains, or penalties based on an individual's alien status, color, or race. specifies that the use of a riot control agent (e.g., tear gas) without a prior clear and audible warning is a punishment, pain, or penalty.
HB-7196: Right to PROTEST Act of 2020
Sponsored by: Rep. Suzanne Bonamici
Introduced In House on 06/15/2020
Prohibiting Law Enforcement Use of Chemical Weapons Act [HB-7221]
[Crime ]
[Public Safety ]
Prohibits federal, state, and local law enforcement officers from using chemical weapons in the course of policing activities. It also requires law enforcement agencies to dispose of chemical weapons that were acquired for such use.
HB-7221: Prohibiting Law Enforcement Use of Chemical Weapons Act
Sponsored by: Rep. Barbara Lee
Introduced In House on 06/15/2020
Intelligence Authorization Act for Fiscal Year 2021 [S.3905]
[Cybersecurity ]
[Telecommunications ]
[Technology and Innovation ]
[National Security ]
[Law Enforcement ]
[Military ]
[Science ]
[Funding ]
[Grants ]
Authorizes various intelligence-related activities for FY2021 and contains other related provisions. The bill's provisions include requiring the Office of the Director of National Intelligence (ODNI), the Central Intelligence Agency (CIA), and other intelligence agencies to establish continuity of operations plans; requiring the ODNI to establish the Social Media Data and Threat Analysis Center; establishing that disclosure of a whistleblower's personally identifiable information may constitute a personnel action and giving the whistleblower a right
(continued...)
S.3905: Intelligence Authorization Act for Fiscal Year 2021
Sponsored by: Sen. Marco Rubio
By Senator Rubio From Select Committee On Intelligence Filed Written Report. Report No. 116-233. Minority Views Filed. on 06/17/2020
PRICE Act Pandemic Response and Interstate Cost Equity Act [S.3858]
[Healthcare ]
[Public Health ]
[Disaster Relief ]
[Funding ]
[Defense ]
[National Security ]
[Pharmaceuticals ]
Establishes the Federal Emergency Management Agency (FEMA) as the sole buyer, vendor, owner, and distributor of certain medical equipment obtained by the federal government in the event of a national health emergency and establishes a process for the pricing and distribution of such equipment. Specifically, in the event of such an emergency, the Department of Health and Human Services shall assess available medical equipment and FEMA shall (1) become the sole owner and distributor of medical equipment obtained by the federal government for which
(continued...)
S.3858: PRICE Act Pandemic Response and Interstate Cost Equity Act
Sponsored by: Sen. Elizabeth Warren
Read Twice And Referred To The Committee On Homeland Security And Governmental Affairs. on 06/01/2020
HOME Act Help Onshore Manufacturing Efficiencies for Drugs and Devices Act [S.3780]
[Healthcare ]
[Manufacturing ]
[Pharmaceuticals ]
[Public Health ]
[Economic Development ]
[National Security ]
[Small Business ]
[Trade ]
A bill to encourage domestic advanced manufacturing of critical drugs and devices in order to address economic, health, and security concerns, combat shortages of critical drugs and devices, and promote increased domestic diversification of, and independence from foreign reliance on, pharmaceutical and medical device supply chains.
S.3780: HOME Act Help Onshore Manufacturing Efficiencies for Drugs and Devices Act
Sponsored by: Sen. Gary Peters
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/20/2020
The Heroes Act [HB-6800]
[Healthcare ]
[Housing ]
[Immigration ]
[Student Loans ]
[Medicare and Medicaid ]
[Taxes ]
[Budget and Spending ]
[Small Business ]
[Consumer Protection ]
[Food ]
[Veterans ]
[Public Health ]
[Mental Health ]
[Children and Youth ]
[Economic Development ]
[Elections ]
[Funding ]
[Grants ]
[Human Services ]
[Pensions ]
[Pharmaceuticals ]
[Poverty ]
[Retirement ]
[Labor, Jobs, Employment ]
[Telecommunications ]
[Transportation and Motor Vehicles ]
[Insurance ]
[Cybersecurity ]
[Data Privacy ]
[Disaster Relief ]
[Unemployment ]
Responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses. Among other things, the bill provides FY2020 emergency supplemental appropriations to federal agencies; provides payments and other assistance to state, local, tribal, and territorial governments; provides additional direct payments of up to $1,200 per individual; expands paid sick days, family and medical leave, unemployment compensation, nutrition and food assistance programs,
(continued...)
HB-6800: The Heroes Act
Sponsored by: Rep. Raul Grijalva
Committee On Small Business And Entrepreneurship. Hearings Held. on 07/23/2020
Stop COVID Act of 2020 Stop China-Originated Viral Infectious Diseases Act of 2020 [S.3592]
[International ]
[Public Health ]
[National Security ]
[Human Rights ]
Limits the immunity of foreign states from suit in the United States. Specifically, it bars immunity for a foreign state in cases where the foreign state allegedly, whether intentionally or unintentionally, discharges a biological agent that results in the bodily injury, death, or damage to property of a U.S. national.
S.3592: Stop COVID Act of 2020 Stop China-Originated Viral Infectious Diseases Act of 2020
Sponsored by: Sen. Martha McSally
Read Twice And Referred To The Committee On The Judiciary. on 05/04/2020
PRICE Act Pandemic Response and Interstate Cost Equity Act [HB-6662]
[Healthcare ]
[Public Health ]
[Disaster Relief ]
[Funding ]
[Defense ]
[National Security ]
[Pharmaceuticals ]
Establishes the Federal Emergency Management Agency (FEMA) as the sole buyer, vendor, owner, and distributor of certain medical equipment obtained by the federal government in the event of a national health emergency and establishes a process for the pricing and distribution of such equipment. Specifically, in the event of such an emergency, the Department of Health and Human Services shall assess available medical equipment and FEMA shall (1) become the sole owner and distributor of medical equipment obtained by the federal government for which
(continued...)
HB-6662: PRICE Act Pandemic Response and Interstate Cost Equity Act
Sponsored by: Rep. Ted Lieu
Referred To The Subcommittee On Economic Development, Public Buildings, And Emergency Management. on 05/04/2020
Director of Pandemic and Biodefense Preparedness and Response Act [HB-6610]
[Healthcare ]
[Public Health ]
[National Security ]
[Science ]
Establishes the position of the Director of Pandemic and Biodefense Preparedness and Response in the executive branch and sets forth the qualifications for and responsibilities of the position. Among other tasks, the director shall advise the President, relevant councils, and others with respect to pandemics and other health threats; oversee the development of a National Pandemic and Biodefense Preparedness and Response Strategy and, in consultation with the Office of Management and Budget, submit biennial reports to Congress on the implementation
(continued...)
HB-6610: Director of Pandemic and Biodefense Preparedness and Response Act
Sponsored by: Rep. Eleanor Norton
Referred To The Subcommittee On Economic Development, Public Buildings, And Emergency Management. on 04/24/2020
Stop COVID Act of 2020 Stop China-Originated Viral Infectious Diseases Act of 2020 [HB-6444]
[International ]
[Public Health ]
[National Security ]
[Human Rights ]
Limits the immunity of foreign states from suit in the United States. Specifically, it bars immunity for a foreign state in cases where the foreign state, whether intentionally or unintentionally, discharges a biological weapon in the United States or that results in the bodily injury of a U.S. citizen.
HB-6444: Stop COVID Act of 2020 Stop China-Originated Viral Infectious Diseases Act of 2020
Sponsored by: Rep. Matt Gaetz
Introduced In House on 04/03/2020
William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 [HB-6395]
[Defense ]
[Cybersecurity ]
[Artificial Intelligence ]
[Military ]
[National Security ]
[Healthcare ]
[Energy ]
[Science ]
[Technology and Innovation ]
[Veterans ]
[Funding ]
[Grants ]
[Aerospace ]
Authorizes FY2021 appropriations and sets forth policies for Department of Defense (DOD) programs and activities, including military personnel strengths. It does not provide budget authority, which is provided in subsequent appropriations legislation. The bill authorizes appropriations to DOD for Procurement, including aircraft, weapons and tracked combat vehicles, shipbuilding and conversion, and missiles; Research, Development, Test, and Evaluation; Operation and Maintenance; Working Capital Funds; Chemical Agents and Munitions Destruction; Drug
(continued...)
HB-6395: William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021
Sponsored by: Rep. Adam Smith
Message On Senate Action Sent To The House. on 01/02/2021
Securing America From Epidemics Act [HB-6334]
[Healthcare ]
[Public Health ]
[International ]
[Pharmaceuticals ]
[Science ]
[National Security ]
Authorizes the United States to participate in the Coalition for Epidemic Preparedness Innovations (CEPI), an alliance of countries and private partners whose mission is to finance and coordinate the development of vaccines for high-priority, epidemic-potential threats. The President must submit a report outlining (1) planned U.S. contributions to, and participation in, CEPI; (2) the manner and extent to which the United States shall participate in the governance of CEPI; and (3) how participation in CEPI supports U.S. government strategies and
(continued...)
HB-6334: Securing America From Epidemics Act
Sponsored by: Rep. Ted Lieu
Received In The Senate And Read Twice And Referred To The Committee On Foreign Relations. on 11/30/2020
VITAL Act of 2020 Verified Innovative Testing in American Laboratories Act of 2020 [S.3512]
[Healthcare ]
[Medicare and Medicaid ]
[Public Health ]
[Science ]
Expressly shifts the regulation of laboratory-developed testing procedures from the Food and Drug Administration (FDA) to the Centers for Medicare & Medicaid Services (CMS). Under current law, the FDA regulates the safety and effectiveness, as well as quality of design and manufacture, of laboratory-developed tests, while the CMS regulates clinical laboratories and testing processes. Historically, the FDA has exercised enforcement discretion and not enforced certain statutory and regulatory requirements with respect to these tests. The CMS must
(continued...)
S.3512: VITAL Act of 2020 Verified Innovative Testing in American Laboratories Act of 2020
Sponsored by: Sen. Rand Paul
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 03/17/2020
Commission on America’s Medical Security Act [HB-6282]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
[National Security ]
[Manufacturing ]
[Trade ]
Requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to report on the security of the U.S. medical product supply chain (i.e., supply of drugs and devices). Among other things, the report shall assess the dependence of the United States, including the private sector, states, and federal government, on critical drugs and devices sourced or manufactured outside of the United States; and provide recommendations to address supply vulnerabilities or potential
(continued...)
HB-6282: Commission on America’s Medical Security Act
Sponsored by: Rep. David Roe
Introduced In House on 03/13/2020